noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Amylyx Pharmaceuticals Inc.

Statement of Changes in Beneficial Ownership (Form 4)
ChargePoint Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)
ChargePoint Holdings Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

Krystal Biotech Inc.

12/23/2025 | Press release | Distributed by Public on 12/23/2025 15:51

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On December 22, 2025, Kirti Ganorkar gave notice of his resignation from the Board of Directors (the "Board") of Krystal Biotech, Inc. (the "Company"). Mr. Ganorkar's decision to resign was due to time constraints arising from increased responsibilities following his recent promotion to Managing Director at Sun Pharma and not the result of any disagreement with the Board or management on any matter related to the Company's operations, policies, or practices. Mr. Ganorkar will continue to serve as a director of the Company through December 31, 2025.

Mr. Ganorkar has served on the Board since the Company went public in September 2017, and the Board thanks him for his years of service and valuable contributions to the Company.

Krystal Biotech Inc. published this content on December 23, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 23, 2025 at 21:51 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]